Till the exhibition
|CBU Currency of 21.11.2017|
|www.cbu.uz||USD = 8085.11|
|EUR = 9487.07|
|RUB = 136.65|
The UzMedExpo exhibition is a demonstration of achievements of domestic and foreign manufacturers. Producer companies and distributors of the medical and dental equipment, pharmaceutical products, clinic will be able to provide the products and services to thousands of professional visitors from various regions of the Republic.
National Exhibition Complex «UzExpoCenter», Pavilion № 2.
Tel.: + 998 71 238 94 68
Fax: + 998 71 238 59 87
Mob.: + 998 93 501 02 78
E-mail: firstname.lastname@example.org; email@example.com
Agency for Development of Pharmaceutical Industry under the Ministry of Health is created in Uzbekistan. At the same time, the concern Uzfarmsanoat is liquidated.
President of Uzbekistan Shavkat Mirziyoyev signed a decree “On measures for cardinal improvement of pharmaceutical industry management system”.
In the decree, the head of state underlined a number of systemic shortcomings in pharmaceutical sector. Domestic industry enterprises are not able to meet the need of population for high-quality and competitive pharmaceutical products.
Of the total number of enterprises, which are part of the Uzfarmsanoat, 19% do not function, in 30% of production is limited to packaging and labeling of finished products.
The decree said that currently total number of names of raw materials, imported for production of medicines, 23.4% is finished goods.
The share of original medicines registered by the enterprises of Uzfarmsanoat is only 1.3%, the document underlined.
According to the decree of the President, the Agency for Development of Pharmaceutical Industry under the Ministry of Health is created in Uzbekistan. At the same time, Shavkat Mirziyoyev liquidated Uzfarmsanoat.
The President of Uzbekistan entrusted the Agency to develop and implement a strategy for sustainable development of pharmaceutical industry, including through implementation of public-private partnerships.
The Agency will coordinate the activities of pharmaceutical enterprises and organizations in implementing programs to provide the population and public health institutions with medicines, medical devices and medical equipment.
The new agency will carry out state registration and certification of medicines, medical products and medical equipment, including those imported from abroad, to certify pharmaceutical enterprises for compliance with international good manufacturing practice rules.
The President handed over the State Center for Expertise and Standardization of Medicines, Medical Devices and Medical Equipment of the Ministry of Health, the Uzbek Chemical and Pharmaceutical Research Institute, the Tashkent Research Institute of Vaccines and Serums, and the Scientific Research Institute Eastern Medicine to the agency.
According to the document, the state enterprise O‘zmedeksport of the Ministry of Health was renamed into the state unitary enterprise O‘zmedimpeks. The head of Uzbekistan transferred O‘zmedimpeks to the Agency.
At the same time, O‘zmedimpeks is defined as a single supplier of socially significant medicines and medical products. It will also be an agent for their storage, processing and delivery
The document said that the Ministry of Health will set fixed prices for medicines and medical products included in the list of socially significant medicines and medical products.
Particular attention in the Decree is paid to the issue of improving the registration procedure, pricing for medicines and medical products, introducing a clear definition of the concept of “in bulk” products in the legislation, as well as the procedure for fixing fixed prices for socially important medicines and medical products.
The Cabinet of Ministers approved the Program of measures for the further development of the dermatovenereological service for 2017-2021. The total volume of the program’s financing is 57.6 billion soums and $6 million.
Within the program, it is projected the construction of regional dermatovenerologic clinics in Qashqadaryo, Navoi and Sirdaryo, as well as the Shahrisabz regional dermatovenerologic hospital. Another eleven similar facilities are subject to reconstruction and one - major repairs.
At the same time, inter-district dermatovenerologic dispensaries will be established in 2018 in Bekobod, Denov, To’rtko’l and Yangiqo’rghon districts, taking into account the maximum coverage of the population living in regions (cities) remote from the regional centers.
And, an experimental scientific laboratory of dermatovenereology and medical cosmetology will be opened in the structure of the Republican Specialized Scientific and Practical Medical Center of Dermatology and Venereology. It will deal with the coordination and methodological work on the development and implementation of modern scientific achievements in this field, monitoring the epidemiological situation and developing effective programs for the prevention of dermatovenereological diseases and their complications.
The Ministry of Health of Uzbekistan will create its own network of social pharmacies.
President of Uzbekistan Shavkat Mirziyoyev on Monday signed a resolution “On additional measures to improve the system of providing the population with medicines and medical products”. Uzbek leader instructed the Ministry of Health together with the Ministry of Economy, the Ministry of Finance, the Ministry for the Development of Information Technologies and Communications, the Ministry of Justice and the State Committee on Assistance to Privatized Enterprises and Competition Development of Uzbekistan to develop a set of measures to create own network of social pharmacies to improve accessibility of socially important medicines and medical products.
The main goal of pharmacies is to sell medicines and medical products to the population at fixed prices.
Establishment of pharmacies should help to increase the availability of socially important medicines and prevent uncontrolled use of medicines by citizens, including through tightening the requirements for dispensing prescription drugs and introducing information systems for monitoring the implementation of such medicines.
The President instructed to introduce an information system, which will monitor realization of socially important medicines dispensed by doctors’ prescriptions.
The Ministry of Finance this year will allocate additional funds for the purchase of medicines and medical products for public health institutions financed from the budget, primarily family clinics, emergency and emergency medical services.
This follows from the Decree of the President of the Republic of Uzbekistan "On Urgent Measures to Reliably Provide the Population of the Republic with the Main Types of Socially Significant Foodstuffs".
Until the end of 2017 for these purposes at the expense of its own foreign exchange resources will be allocated additional funds in the amount equivalent to $ 70 million.
The Ministry of Finance was also instructed to provide for the maintenance of increased budgetary allocations for these purposes in the State Budget of the Republic of Uzbekistan for 2018 and subsequent years.
In Uzbekistan, there was another region in which roentgenendovascular surgery began to be applied - it is Samarkand.
The department of roentgenendovascular surgery was put into operation in the Samarkand regional multiprofile medical center. The center has a modern angiograph from Holland, which will allow treating patients who had previously been forced to travel to Tashkent clinics or travel abroad.
Today roentgenendovascular surgery has become the gold standard not only for reliable diagnosis of the state of blood vessels, including the heart, but also for the restoration of their normal functioning.
In Uzbekistan, these technologies for a long time remained the attribute of the leading republican medical centers. However, the last three years it began to be introduced actively in the regions. During this time, experience has been accumulated in Ferghana, Namangan, and Nukus. In the coming months, such equipment will begin operating in three other regions.
The Program of Measures for the Further Development of Specialized Medical Aid to the Population of the Republic of Uzbekistan for 2017-2021 was approved.
As part of the program to develop the development of specialized medical services in the Republic of Uzbekistan, more than 373.5 billion soums and more than $ 100 million have been allocated, of which 60 billion soums will be spent on the construction, reconstruction and overhaul of the facilities of the republican specialized scientific and practical medical centers and more than $ 97 - to equip the republican and territorial specialized medical institutions with the most modern medical equipment.
The implementation of the measures proposed in the framework of the resolutions and programs will help to raise the quality of the services provided in the republic to a new level, especially at the regional and district levels (urban) levels, broadening the access of the broad strata of the population to obtaining high-tech assistance, introducing the latest achievements in research activities And advanced foreign experience in the provision of high-tech specialized medical services.
Dr. Jatinder Cheema, Regional Mission Director, U.S. Agency for International Development/Central Asia and Dr. Mirzanazim Dusmuratov, Chairman of Board of the Uzbek State Joint Stock Pharmaceutical Company, Uzpharmsanoat, participated in a signing ceremony to formalize cooperation between Uzpharmsanoat and USAID on the implementation of the “Promoting the Quality of Medicines” Project in Uzbekistan.
Officials from Uzpharmsanoat and the Uzbek Ministries of Health and Foreign Affairs, as well as other health officials and stakeholders attended the ceremony at the Uzpharmsanoat office, the US Embassy in Tashkent said.
Although the pharmaceutical industry in Uzbekistan has made considerable progress in recent years, the government has continued to prioritize improving the quality of domestically produced medicines and medical products. Currently, 146 enterprises in Uzbekistan are engaged in the production of more than two thousand medicines and medical products. Uzpharmsanoat is the largest state joint stock company of the pharmaceutical industry in Uzbekistan.
The USAID project, implemented by the United States Pharmacopeia Convention, a nonprofit scientific organization that sets standards for the identity, strength, quality, and purity of medicines manufactured, distributed, and consumed worldwide, will work with Uzpharmsanoat to achieve and maintain good manufacturing practices and quality standards. USAIDs assistance will also help manufacturers of TB medicines comply with international Good Manufacturing Standards and prepare for approval by the World Health Organization’s Pre Qualifications program, the only global medicines quality assurance program in the world.
Noting the importance of this USAID collaboration, Dr. Cheema told the ceremony participants, “Tuberculosis, now the world’s biggest killer among infectious diseases, remains a serious concern in Central Asia. USAID is pleased to be working with the Government of Uzbekistan and Uzpharmsanoat to ensure that the medicines produced in Uzbekistan meet the highest standards of quality, safety and efficacy and are available to effectively treat TB patients here and throughout the region.”
USAID supports GOUs efforts to reduce the burden of tuberculosis. USAID’s cooperation with the GOU has improved tuberculosis control, helped to reduce morbidity and mortality, and contributed to a decrease in tuberculosis cases and deaths compared to a decade ago. Since 1993, USAID has provided more than $356 million in assistance to Uzbekistan.
Agency for Development of Pharmaceutical Industry created in Uzbekistan.21 August 2017
Dermatological Service Development Program Approved.19 July 2017
Uzbek Health Ministry to create network of social pharmacies.06 July 2017
To purchase medicines for family polyclinics and ambulance $ 70 million is additionally allocated.23 June 2017
Roentgenendovascular surgery began to develop in Samarkand.23 June 2017
Over 373.5 billion soums and more than $ 100 million have been allocated for the development of specialized medical care.